Pharmaceutical companies under intense scrutiny
Pharma Compliance Alert, November 14, 2007
Editor's note: This is the first in a two-part series on OIG chief counsel Lewis Morris' remarks at last week's Pharmaceutical Regulatory and Compliance Congress.
The pharmaceutical industry is under "intense scrutiny" across the country, OIG chief counsel Lewis Morris told industry insiders at last week's Pharmaceutical Regulatory and Compliance Congress in Washington, DC.
Morris said the public perception of relationships between pharmaceutical companies and physicians is "troubling to people". Morris said news coverage of pharmaceutical companies' spending increases the perception that physicians are being unjustly influenced by the industry.
In response, many medical centers and medical schools have eliminated industry-sponsored lunches and have cut down on the number of visits by pharmaceutical representatives they permit.
Morris also expects to see more states pass their own versions of the False Claims Act and believes that pharmaceutical companies will continue to face more lawsuits under the this law.
"More prosecutors are able to build and pursue these cases," Morris said, noting that settlements are coming from more than just the Boston and Philadelphia U.S. Attorney's Offices, such as Virginia and Florida.
Related Products
-
ePharm5 InDepth
EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...
-
Big Pharma Performance Before, During and Beyond the Global Recession
This report assesses the performance of the leading 15 pharmaceutical companies up to, during and beyond the recent global...
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- Capturing all necessary codes for IUD insertion and removal can be challenging
- What does case-mix index mean to you?
- QA:Coding multiple initial infusions
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- HIPAA Q&A: Level of encryption needed for email
- OB services: Coding inside and outside of the package
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Q/A. One injection code or two?
- What does case-mix index mean to you?
- ED-to-inpatient transfers are flawed with safety gaps
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Searched